Differential actions of follistatin and follistatin-like 3

被引:51
作者
Schneyer, A
Sidis, Y
Xia, Y
Saito, S
del Re, E
Lin, HY
Keutmann, H
机构
[1] Massachusetts Gen Hosp, Reprod Endocrine Unit, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Program Membrane Biol, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Renal Unit, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA
关键词
follistatin; follistatin-like; 3; FLRG; FSRP; activin; structure; activity;
D O I
10.1016/j.mce.2004.02.009
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Follistatin (FS) is an important physiological regulator of activin and other TGFbeta superfamily members. The recently discovered follistatinlike 3 (FSTL3; a.k.a. FLRG; FSRP) shares significant structural and functional homology with FS, but also has some interesting differences, including a prominent nuclear localization. The existence of these two related proteins allows detailed molecular and biochemical comparisons of the biologic roles of their individual structural elements. Current studies indicate that the heparin binding sequence is essential for the ability of FS to inhibit autocrine activin but is not sufficient to confer this activity on FSTL3. Preliminary analysis of FSTL3 transgenic mice suggests that FSTL3 regulates gonadal development and function through inhibition of the paracrine activity of activin and/or other related factors. These studies have identified important structural elements necessary for biological activity of FS and FSTL3 and potential roles for FSTL3 in vivo. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:25 / 28
页数:4
相关论文
共 19 条
[1]   A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse [J].
Nolan, PM ;
Peters, J ;
Strivens, M ;
Rogers, D ;
Hagan, J ;
Spurr, N ;
Gray, IC ;
Vizor, L ;
Brooker, D ;
Whitehill, E ;
Washbourne, R ;
Hough, T ;
Greenaway, S ;
Hewitt, M ;
Liu, XH ;
McCormack, S ;
Pickford, K ;
Selley, R ;
Wells, C ;
Tymowska-Lalanne, Z ;
Roby, P ;
Glenister, P ;
Thornton, C ;
Thaung, C ;
Stevenson, JA ;
Arkell, R ;
Mburu, P ;
Hardisty, R ;
Kiernan, A ;
Erven, H ;
Steel, KP ;
Voegeling, S ;
Guenet, JL ;
Nickols, C ;
Sadri, R ;
Naase, M ;
Isaacs, A ;
Davies, K ;
Browne, M ;
Fisher, EMC ;
Martin, J ;
Rastan, S ;
Brown, SDM ;
Hunter, J .
NATURE GENETICS, 2000, 25 (04) :440-443
[2]   Proliferative phase Sertoli cells display a developmentally regulated response to activin in vitro [J].
Buzzard, JJ ;
Farnworth, PG ;
de Kretser, DM ;
O'Connor, AE ;
Wreford, NG ;
Morrison, JR .
ENDOCRINOLOGY, 2003, 144 (02) :474-483
[3]   Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-β superfamily -: Specialized binding regions for transforming growth factor-β and inhibin A [J].
Esparza-López, J ;
Montiel, JL ;
Vilchis-Landeros, MM ;
Okadome, T ;
Miyazono, K ;
López-Casillas, F .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (18) :14588-14596
[4]   Overexpression of mouse follistatin causes reproductive defects in transgenic mice [J].
Guo, QX ;
Kumar, TR ;
Woodruff, T ;
Hadsell, LA ;
DeMayo, FJ ;
Matzuk, MM .
MOLECULAR ENDOCRINOLOGY, 1998, 12 (01) :96-106
[5]   FLRG (follistatin-related gene), a new target of chromosomal rearrangement in malignant blood disorders [J].
Hayette, S ;
Gadoux, M ;
Martel, S ;
Bertrand, S ;
Tigaud, I ;
Magaud, JP ;
Rimokh, R .
ONCOGENE, 1998, 16 (22) :2949-2954
[6]   The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum [J].
Hill, JJ ;
Davies, MV ;
Pearson, AA ;
Wang, JH ;
Hewick, RM ;
Wolfman, NM ;
Qiu, YC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (43) :40735-40741
[7]   LOCALIZATION OF THE HEPARIN BINDING-SITE OF FOLLISTATIN [J].
INOUYE, S ;
LING, N ;
SHIMASAKI, S .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1992, 90 (01) :1-6
[8]   Regulation of myostatin activity and muscle growth [J].
Lee, SJ ;
McPherron, AC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (16) :9306-9311
[9]   Betaglycan binds inhibin and can mediate functional antagonism of activin signalling [J].
Lewis, KA ;
Gray, PC ;
Blount, AL ;
MacConnell, LA ;
Wiater, E ;
Bilezikjian, LM ;
Vale, W .
NATURE, 2000, 404 (6776) :411-414
[10]   MULTIPLE DEFECTS AND PERINATAL DEATH IN MICE DEFICIENT IN FOLLISTATIN [J].
MATZUK, MM ;
LU, NF ;
VOGEL, H ;
SELLHEYER, K ;
ROOP, DR ;
BRADLEY, A .
NATURE, 1995, 374 (6520) :360-363